# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Adial Pharmaceuticals (NASDAQ:ADIL) reported quarterly losses of $(0.59) per share. This is a 55.64 percent increase over losse...
Adial Pharmaceuticals (NASDAQ:ADIL) reported quarterly losses of $(2.19) per share which missed the analyst consensus estimate ...